Investor Presentaiton

Q2-23 Consolidated Results $147M Gross New Contract Signings $1.2B Backlog Revenues (in millions of $) 169 161 150 142 148 Gross Profit & Margin (in millions of $, except margin) 6% Organic Growth 13% Acquisitive Growth Adj. EBITDA¹ & Margin¹ (in millions of $, except margin) 52 19.1 50 46 45 16.8 16.1 40 30.9% 31.2% 30.3% 30.6% 28.1% Q2-22 Q3-22 Q4-22 Q1-23 Q2-23 Q2-22 Q3-22 Q4-22 Gross Profit Q1-23 Gross Margin Q2-23 16.8 14.3 11.9% 11.8% 10.0% 10.7% 9.7% Q2-22 Q3-22 Q4-22 Q1-23 Q2-23 Adj. EBITDA Adj. EBITDA Margin 1) This is a non-GAAP measure. Please refer to the MD&A. 19% revenue growth (Q2-23 vs Q2-22) and gross margin in excess of 30% for the 4th consecutive quarter 40 67 40 YEARS OF CALIAN

View entire presentation